HealthLeaders Media February 7, 2024
Christopher Cheney

A proposed regulatory strategy for artificial intelligence in healthcare settings is compared to regulatory standards for new drugs.

KEY TAKEAWAYS

– By focusing on patient outcomes, healthcare artificial intelligence regulation can avoid an emphasis on revenue-generating opportunities for the technology.

– At Allegheny Health Network and Providence, the health systems are using AI technology that impacts patient outcomes such as an AI tool that uses 3D imaging to scan for skin abnormalities and an AI tool that connects patients with clinical trials.

– Healthcare artificial intelligence regulation should balance the right utilization of the technology with the right guardrails, Allegheny Health Network’s CMO says.

A trio of experts is proposing companies that produce artificial intelligence (AI) tools in healthcare should...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Govt Agencies, Patient / Consumer, Provider, Regulations, Technology
The case for human-centered AI
European Commission Approves Nvidia’s Proposed Acquisition of Run:ai
How Health Systems Can Collaborate on AI Tools
The Future Talent Equation: How To Identify And Retain Talent In The Age Of AI
A Roadmap For AI In Education: Turning Disruption Into Opportunity

Share This Article